Table 1.

Patient characteristics (n = 35).

n = 35
Sex ratio	1.2
Men (n; %)	19	(54.3%)
Age (years; SD)	66	±16
Underlying cardiovascular disease:
(i) Preexisting cardiomyopathy (n; %)	21	(60%)
LVEF (%; SD)	39.7	±14
(ii) Chronic atrial fibrillation (n; %)	11	(31.5%)
SAPSII (n; SD)	54	±21
Causes of cardiogenic shock: (n; %)
(i) Acute myocardial infarction	15	(42.9%)
(ii) End-stage cardiomyopathy	6	(17.1%)
(iii) Treatment toxicity (chemotherapy)	5	(14.3%)
(iv) Myocarditis	2	(5.7%)
(v) Complex heart rhythm disorder	2	(5.7%)
(vi) Thyrotoxicosis	1	(2.9%)
(vii) Unknown	4	(11.4%)
Need for life support techniques in ICU: (n; %)
(i) Renal replacement therapy	12	(34.3%)
(ii) Mechanical ventilation	22	(62.8%)
(iii) Norepinephrine use	25	(71%)
(iv) Epinephrine use	1	(2.8%)
(v) Dobutamine use	35	(100%)
Mortality in the ICU (n; %)	19	(54%)

LVEF: left ventricular ejection function; SAPSII: simplified acute physiology score II; ICU: intensive care unit.